Global Synthetic siRNA Market size was valued at USD 3.50 Bn. in 2024 and the total Synthetic siRNA Market revenue is expected to grow by 10.1% from 2025 to 2032, reaching nearly USD 7.56 Bn, growth is driven by rising prevalence of chronic diseases and increasing R&D investments in gene-silencing therapies.Synthetic siRNA Market Overview
Synthetic siRNA are also known as short interfering RNA, which is a type of non-coding double stranded RNA of 20-23 nucleotide base pairs in length. It is a powerful tool used for modulating gene expression by RNA interference (RNAi).siRNAs consist of two RNA strands, an antisense (or guide) strand and a sense (or passenger) strand, which form a duplex 19 to 25 bp in length with 3' dinucleotide overhangs. siRNA are transfected into cells by using delivery methods like polymer-based transfection reagents, electroporation or by adding chemical modifications.To Know About The Research Methodology :- Request Free Sample Report
Synthetic siRNA Market Dynamics
Increasing applications in gene therapy is the major factor driving the market. Gene therapy offers a promising therapeutic platform as it targets disease-causing genes in a sequence-specific manner, which enables more precise and personalized treatment of diverse life-threatening diseases. Global prevalence of chronic diseases like cancer is noticing increasing number of applications in molecular diagnostics and incorporation of RNAi techniques in personalized medicines. Other advantages of siRNA include the high efficiency of the gene knockdown, the ability to easily target the gene of interest, as well as stable and long-term silencing by expressing shRNAs are accelerating the market growth. However, many challenges related to siRNA may limit the market growth. One of the biggest challenge to siRNA based therapeutics is its intracellular delivery, as it has weak stability and pharmacokinetic behavior. It also faces problem of off-targeting during delivery since genes are read in both directions, there exists a possibility that even if the intended antisense siRNA strand is read and knocks out the target mRNA, the sense siRNA strand may target another protein involved in another function. In recent years, there has been a decline in FDA drug approval rates. Getting FDA approval for a new drug has become extremely challenging. It approved less than half the number of new drugs in 2016 (19 so far) when compared to 2015 (45 total).Along with this, high cost of synthesis of required siRNA may hamper the market growth. The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.Synthetic siRNA Market Segment Analysis:
Based on applications, the oncology segment is expected to hold larger market share of XX% by 2032. According to the WHO, cancer is the second leading cause of death globally. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Cancer-causing infections, such as hepatitis and human papillomavirus (HPV), are responsible for approximately 30% of cancer cases in low- and lower-middle-income countries. High-risk human papillomaviruses infect skin and mucosa, causing approximately 5% of cancers worldwide. The selected siRNA prevents the tumor from growing via RNAi to decrease expression of the M2 subunit of R2 (ribonucleotide reductase). Based on Delivery Mode, the Global Synthetic SiRNA Market is segmented into Lipid Based siRNA, Nanoparticle-Based siRNA and Others. Among these Lipid-Based siRNA delivery segment has dominated the Synthetic siRNA market in 2024 and is expected to hold largest market share forecast period, because they can effectively protect and deliver siRNA molecules, providing different levels of encapsulation and cellular uptake efficiencies for gene silencing. The lipid-based delivery systems that we have studied have been well characterized, relatively easy to manufacture in large quantities, and shown good to excellent safety and efficacy profiles in preclinical and clinical studies. Additionally, with the recent regulatory approvals and success stories related to lipid nanoparticle-based RNA therapeutics (e.g. mRNA vaccine development), there have been increased investments and innovations related to lipid-based siRNA delivery systems, further strengthening their competitive advantages in the siRNA market.Synthetic siRNA Market Regional Insights:
North America dominates the global market and is expected to continue the dominance throughout the forecast period. The US leads the global market owing to huge number of RNAi therapeutics in the development stage. High investments from biotechnology companies for the development of novel therapeutics is contributing to the market growth in the region. Rising prevalence of personalized medicines for life threatening diseases like cancer, HIV drives the demand for Synthetic siRNA market. For instance, AstraZeneca's agreement with Ionis pharmaceuticals is one of the big deals that are investing heavily into RNA-interference technology. According to the news released on 10th August 2018, the US Food and Drug Administration approved Onpattro (patisiran) infusion for the treatment of polyneuropathy. Recently, the FDA-approved GIVLAARI (givosiran, ALN-AS1) for the treatment of adults with acute hepatic porphyria (AHP). The report also helps in understanding Global Synthetic siRNA Market dynamics, structure by analyzing the market segments and project the Global Synthetic siRNA Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Synthetic siRNA Market make the report investor’s guide.
Scope of the global Synthetic siRNA Market report: Inquire before buying
Synthetic siRNA Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 3.50 Bn. Forecast Period 2025 to 2032 CAGR: 10.1% Market Size in 2032: USD 7.56 Bn. Segments Covered: by Tools Libraries Software Vectors by Application Oncology Hepatitis HIV Infection by Indication Hereditary Transthyretin-mediated Amyloidosis Acute Hepatic Porphyria Primary Hyperoxaluria Type 1 Primary Hypercholesterolemia Others by Delivery Mode Lipid Based siRNA Nanoparticle-Based siRNA Others Synthetic siRNA Market, by Region:
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, ASEAN, Indonesia, Philippines, Malaysia, Vietnam, Thailand, ASEAN, Rest of Asia Pacific) Middle East & Africa (South Africa, GCC, Nigeria, Rest of ME&A) South America (Brazil, Argentina, Rest of South America)Synthetic siRNA Market Key players
1. Thermo Fisher Scientific Inc. 2. Bioneer 3. Dharmacon (ThermoFisher) 4. Invitrogen 5. Integrated DNA Technologies 6. MWG Biotech 7. OligoEngine 8. Proligo (Sigma) 9. Qiagen 10.AstraZeneca 11.Ionis pharmaceuticals 12.Alnylam Pharmaceuticals 13.Arcturus Therapeutics 14.Dicerna Pharmaceuticals 15.Merck & Co. Inc. (Sigma Aldrich) Frequently Asked Questions: 1. Which region has the largest share in the Global Synthetic siRNA Market? Ans: The North America region held the highest share in 2024. 2. What is the growth rate of the Global Synthetic siRNA Market? Ans: The Global Market is expected to grow at a CAGR of 10.1% during the forecast period 2025-2032. 3. What is the scope of the Global Synthetic siRNA Market report? Ans: The Global Synthetic siRNA Market report helps with the PESTEL, PORTER, Recommendations for Investors and leaders, and market estimation for the forecast period. 4. Who are the key players in the Synthetic siRNA Market? Ans: The important key players in the Global Synthetic siRNA Market are – Thermo Fisher Scientific Inc., Bioneer, Dharmacon (ThermoFisher), Invitrogen, Integrated DNA Technologies, MWG Biotech, OligoEngine, etc. 5. What is the study period of Synthetic siRNA market? Ans: The Global Synthetic siRNA Market is studied from 2024 to 2032.
1. Synthetic siRNA Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Synthetic siRNA Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Synthetic siRNA Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Synthetic siRNA Market: Dynamics 3.1. Synthetic siRNA Market Trends by Region 3.1.1. North America Synthetic siRNA Market Trends 3.1.2. Europe Synthetic siRNA Market Trends 3.1.3. Asia Pacific Synthetic siRNA Market Trends 3.1.4. Middle East and Africa Synthetic siRNA Market Trends 3.1.5. South America Synthetic siRNA Market Trends 3.2. Synthetic siRNA Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Synthetic siRNA Market Drivers 3.2.1.2. North America Synthetic siRNA Market Restraints 3.2.1.3. North America Synthetic siRNA Market Opportunities 3.2.1.4. North America Synthetic siRNA Market Challenges 3.2.2. Europe 3.2.2.1. Europe Synthetic siRNA Market Drivers 3.2.2.2. Europe Synthetic siRNA Market Restraints 3.2.2.3. Europe Synthetic siRNA Market Opportunities 3.2.2.4. Europe Synthetic siRNA Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Synthetic siRNA Market Drivers 3.2.3.2. Asia Pacific Synthetic siRNA Market Restraints 3.2.3.3. Asia Pacific Synthetic siRNA Market Opportunities 3.2.3.4. Asia Pacific Synthetic siRNA Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Synthetic siRNA Market Drivers 3.2.4.2. Middle East and Africa Synthetic siRNA Market Restraints 3.2.4.3. Middle East and Africa Synthetic siRNA Market Opportunities 3.2.4.4. Middle East and Africa Synthetic siRNA Market Challenges 3.2.5. South America 3.2.5.1. South America Synthetic siRNA Market Drivers 3.2.5.2. South America Synthetic siRNA Market Restraints 3.2.5.3. South America Synthetic siRNA Market Opportunities 3.2.5.4. South America Synthetic siRNA Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Synthetic siRNA Industry 3.8. Analysis of Government Schemes and Initiatives For Synthetic siRNA Industry 3.9. Synthetic siRNA Market Trade Analysis 3.10. The Global Pandemic Impact on Synthetic siRNA Market 4. Synthetic siRNA Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 4.1.1. Libraries 4.1.2. Software 4.1.3. Vectors 4.2. Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 4.2.1. Oncology 4.2.2. Hepatitis 4.2.3. HIV Infection 4.3. Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 4.3.1. Hereditary Transthyretin-mediated Amyloidosis 4.3.2. Acute Hepatic Porphyria 4.3.3. Primary Hyperoxaluria Type 1 4.3.4. Primary Hypercholesterolemia 4.3.5. Others 4.4. Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 4.4.1. Lipid Based siRNA 4.4.2. Nanoparticle-Based siRNA 4.4.3. Others 4.5. Synthetic siRNA Market Size and Forecast, by Region (2024-2032) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Synthetic siRNA Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 5.1.1. Libraries 5.1.2. Software 5.1.3. Vectors 5.2. North America Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 5.2.1. Oncology 5.2.2. Hepatitis 5.2.3. HIV Infection 5.3. North America Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 5.3.1. Hereditary Transthyretin-mediated Amyloidosis 5.3.2. Acute Hepatic Porphyria 5.3.3. Primary Hyperoxaluria Type 1 5.3.4. Primary Hypercholesterolemia 5.3.5. Others 5.4. North America Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 5.4.1. Lipid Based siRNA 5.4.2. Nanoparticle-Based siRNA 5.4.3. Others 5.5. North America Synthetic siRNA Market Size and Forecast, by Country (2024-2032) 5.5.1. United States 5.5.1.1. United States Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 5.5.1.1.1. Libraries 5.5.1.1.2. Software 5.5.1.1.3. Vectors 5.5.1.2. United States Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 5.5.1.2.1. Oncology 5.5.1.2.2. Hepatitis 5.5.1.2.3. HIV Infection 5.5.1.3. United States Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 5.5.1.3.1. Hereditary Transthyretin-mediated Amyloidosis 5.5.1.3.2. Acute Hepatic Porphyria 5.5.1.3.3. Primary Hyperoxaluria Type 1 5.5.1.3.4. Primary Hypercholesterolemia 5.5.1.3.5. Others 5.5.1.4. United States Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 5.5.1.4.1. Lipid Based siRNA 5.5.1.4.2. Nanoparticle-Based siRNA 5.5.1.4.3. Others 5.5.2. Canada 5.5.2.1. Canada Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 5.5.2.1.1. Libraries 5.5.2.1.2. Software 5.5.2.1.3. Vectors 5.5.2.2. Canada Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 5.5.2.2.1. Oncology 5.5.2.2.2. Hepatitis 5.5.2.2.3. HIV Infection 5.5.2.3. Canada Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 5.5.2.3.1. Hereditary Transthyretin-mediated Amyloidosis 5.5.2.3.2. Acute Hepatic Porphyria 5.5.2.3.3. Primary Hyperoxaluria Type 1 5.5.2.3.4. Primary Hypercholesterolemia 5.5.2.3.5. Others 5.5.2.4. Canada Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 5.5.2.4.1. Lipid Based siRNA 5.5.2.4.2. Nanoparticle-Based siRNA 5.5.2.4.3. Others 5.5.3. Mexico 5.5.3.1. Mexico Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 5.5.3.1.1. Libraries 5.5.3.1.2. Software 5.5.3.1.3. Vectors 5.5.3.2. Mexico Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 5.5.3.2.1. Oncology 5.5.3.2.2. Hepatitis 5.5.3.2.3. HIV Infection 5.5.3.3. Mexico Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 5.5.3.3.1. Hereditary Transthyretin-mediated Amyloidosis 5.5.3.3.2. Acute Hepatic Porphyria 5.5.3.3.3. Primary Hyperoxaluria Type 1 5.5.3.3.4. Primary Hypercholesterolemia 5.5.3.3.5. Others 5.5.3.4. Mexico Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 5.5.3.4.1. Lipid Based siRNA 5.5.3.4.2. Nanoparticle-Based siRNA 5.5.3.4.3. Others 6. Europe Synthetic siRNA Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.2. Europe Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.3. Europe Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.4. Europe Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5. Europe Synthetic siRNA Market Size and Forecast, by Country (2024-2032) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.1.2. United Kingdom Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.1.3. United Kingdom Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.1.4. United Kingdom Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5.2. France 6.5.2.1. France Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.2.2. France Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.2.3. France Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.2.4. France Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5.3. Germany 6.5.3.1. Germany Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.3.2. Germany Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.3.3. Germany Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.3.4. Germany Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5.4. Italy 6.5.4.1. Italy Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.4.2. Italy Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.4.3. Italy Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.4.4. Italy Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5.5. Spain 6.5.5.1. Spain Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.5.2. Spain Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.5.3. Spain Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.5.4. Spain Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5.6. Sweden 6.5.6.1. Sweden Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.6.2. Sweden Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.6.3. Sweden Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.6.4. Sweden Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5.7. Austria 6.5.7.1. Austria Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.7.2. Austria Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.7.3. Austria Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.7.4. Austria Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 6.5.8.2. Rest of Europe Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 6.5.8.3. Rest of Europe Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 6.5.8.4. Rest of Europe Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7. Asia Pacific Synthetic siRNA Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.2. Asia Pacific Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.3. Asia Pacific Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.4. Asia Pacific Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5. Asia Pacific Synthetic siRNA Market Size and Forecast, by Country (2024-2032) 7.5.1. China 7.5.1.1. China Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.1.2. China Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.1.3. China Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.1.4. China Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.2. S Korea 7.5.2.1. S Korea Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.2.2. S Korea Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.2.3. S Korea Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.2.4. S Korea Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.3. Japan 7.5.3.1. Japan Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.3.2. Japan Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.3.3. Japan Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.3.4. Japan Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.4. India 7.5.4.1. India Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.4.2. India Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.4.3. India Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.4.4. India Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.5. Australia 7.5.5.1. Australia Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.5.2. Australia Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.5.3. Australia Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.5.4. Australia Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.6. Indonesia 7.5.6.1. Indonesia Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.6.2. Indonesia Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.6.3. Indonesia Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.6.4. Indonesia Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.7. Malaysia 7.5.7.1. Malaysia Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.7.2. Malaysia Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.7.3. Malaysia Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.7.4. Malaysia Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.8. Vietnam 7.5.8.1. Vietnam Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.8.2. Vietnam Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.8.3. Vietnam Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.8.4. Vietnam Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.9. Taiwan 7.5.9.1. Taiwan Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.9.2. Taiwan Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.9.3. Taiwan Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.9.4. Taiwan Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 7.5.10.2. Rest of Asia Pacific Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 7.5.10.3. Rest of Asia Pacific Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 7.5.10.4. Rest of Asia Pacific Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 8. Middle East and Africa Synthetic siRNA Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 8.2. Middle East and Africa Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 8.3. Middle East and Africa Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 8.4. Middle East and Africa Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 8.5. Middle East and Africa Synthetic siRNA Market Size and Forecast, by Country (2024-2032) 8.5.1. South Africa 8.5.1.1. South Africa Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 8.5.1.2. South Africa Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 8.5.1.3. South Africa Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 8.5.1.4. South Africa Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 8.5.2. GCC 8.5.2.1. GCC Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 8.5.2.2. GCC Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 8.5.2.3. GCC Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 8.5.2.4. GCC Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 8.5.3. Nigeria 8.5.3.1. Nigeria Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 8.5.3.2. Nigeria Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 8.5.3.3. Nigeria Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 8.5.3.4. Nigeria Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 8.5.4.2. Rest of ME&A Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 8.5.4.3. Rest of ME&A Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 8.5.4.4. Rest of ME&A Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 9. South America Synthetic siRNA Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 9.2. South America Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 9.3. South America Synthetic siRNA Market Size and Forecast, by Indication(2024-2032) 9.4. South America Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 9.5. South America Synthetic siRNA Market Size and Forecast, by Country (2024-2032) 9.5.1. Brazil 9.5.1.1. Brazil Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 9.5.1.2. Brazil Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 9.5.1.3. Brazil Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 9.5.1.4. Brazil Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 9.5.2. Argentina 9.5.2.1. Argentina Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 9.5.2.2. Argentina Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 9.5.2.3. Argentina Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 9.5.2.4. Argentina Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Synthetic siRNA Market Size and Forecast, by Tools (2024-2032) 9.5.3.2. Rest Of South America Synthetic siRNA Market Size and Forecast, by Application (2024-2032) 9.5.3.3. Rest Of South America Synthetic siRNA Market Size and Forecast, by Indication (2024-2032) 9.5.3.4. Rest Of South America Synthetic siRNA Market Size and Forecast, by Delivery Mode (2024-2032) 10. Company Profile: Key Players 10.1. Thermo Fisher Scientific Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Bioneer 10.3. Dharmacon (ThermoFisher) 10.4. Invitrogen 10.5. Integrated DNA Technologies 10.6. MWG Biotech 10.7. OligoEngine 10.8. Proligo (Sigma) 10.9. Qiagen 10.10. AstraZeneca 10.11. Ionis pharmaceuticals 10.12. Alnylam Pharmaceuticals 10.13. Arcturus Therapeutics 10.14. Dicerna Pharmaceuticals 10.15. Merck & Co. Inc. (Sigma Aldrich) 11. Key Findings 12. Industry Recommendations 13. Synthetic siRNA Market: Research Methodology 14. Terms and Glossary
